Spaczyński Marek, Malkowska-Walczak Blanka, Nowak-Markwitz Ewa
Klinika Onkologii Ginekologicznej Katedry Ginekologii i Połoznictwa Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu.
Ginekol Pol. 2007 Sep;78(9):696-700.
Human papillomavirus (HPV) persistent infection is the main factor leading to the cervical cancer carcinogenesis. Wide-spread public vaccination against HPV as primary prevention is expected to reduce cervical cancer incidence and mortality rates. It is essential to bear in mind that screening for precancerous lesions cannot be discontinued because vaccination will not protect the patients against HPV types which have not been included in the first and second generation of vaccines.
人乳头瘤病毒（HPV）持续感染是导致宫颈癌发生的主要因素。广泛开展针对HPV的公众疫苗接种作为一级预防措施，有望降低宫颈癌的发病率和死亡率。必须牢记，不能停止对癌前病变的筛查，因为疫苗接种并不能保护患者免受第一代和第二代疫苗未涵盖的HPV型别的感染。
